• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Soy supplementation does not reduce risk of prostate cancer recurrence

bys25qthea
July 9, 2013
in Chronic Disease, Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Daily soy protein powder consumption for 2 years following radical prostatectomy did not reduce biochemical recurrence of prostate cancer in men at high risk of PSA failure. 

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Daily soy supplementation taken as a powder for two years was not shown to reduce the recurrence of prostate cancer following radical prostatectomy as measured by PSA levels at regular intervals. It is thought that Asian countries may have lower instances of prostate cancer due to higher levels of soy in the diet. With the growing popularity of supplements, especially various protein powders, this was an informative study for many men. This trial that ended early shows that soy protein powder is not superior to casein-based powder in preventing recurrence. The potential protective mechanism of action of soy isoflavones still should not be fully ruled out. This study examined the role of soy in secondary and tertiary prevention when cancer had already declared itself, but there still may be a role for soy isoflavones in primary prevention of cancers.

Click to read the study, published today in JAMA

Relevant Reading: Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis

In-Depth [randomized study]: This study included 177 patients from 7 centers who were randomized to taking soy protein powder or a casein protein powder (placebo) from 1997-2010. Participants had undergone radical prostatectomy for clinically localized prostate cancer less than 4 months before randomization and had a postsurgery PSA value of less than 0.07 ng/mL. They also fulfilled 1 or more of the following criteria for high risk: preoperative PSA of greater than 20.0 ng/mL, final Gleason score of 8 or greater, established positive surgical margins (but not apical margins), established extracapsular extension (but not in the bladder neck), seminal vesicle invasion, or micrometastases in any removed pelvic lymph nodes. PSA levels were checked at regular intervals, and the primary end points of this trial were the 2-year rate of biochemical recurrence (0.07 ng/mL or higher) and time to recurrence. A blinded interim analysis was conducted once 45 participants had developed recurrence. The trial was ended early because biochemical recurrence of prostate cancer after radical prostatectomy was not shown to be reduced.

RELATED REPORTS

Virtual yoga and meditation intervention may be associated with increased health-related quality of life

2 Minute Medicine Rewind, May 16

Abiraterone plus prednisone improves survival in patients with de novo metastatic castration-sensitive prostate cancer

By Mike Hoaglin and Brittany Hasty

More from this author: Gastric bypass surgery reduces cardio-metabolic risk factors, Dual-chamber ICDs fail to offer benefit over single chamber ICDs, Childhood migraine associated with infantile colic

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: healthoncologyprostateprostate cancersoy
Previous Post

2 Minute Medicine Rewind: July 1 – July 7

Next Post

Link of low vitamin D with coronary heart disease varies by race

RelatedReports

Exercise intervention linked to reduced functional decline among elderly patients admitted to the hospital
Wellness

Virtual yoga and meditation intervention may be associated with increased health-related quality of life

May 20, 2022
Image-guided percutaneous drainage of pericardial effusions is safe and effective
Weekly Rewinds

2 Minute Medicine Rewind, May 16

May 16, 2022
Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial
Chronic Disease

Abiraterone plus prednisone improves survival in patients with de novo metastatic castration-sensitive prostate cancer

May 11, 2022
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Weekly Rewinds

2 Minute Medicine Rewind May 2, 2022

May 2, 2022
Next Post
Maternal vitamin D status does not affect offspring’s bone-mineral content

Link of low vitamin D with coronary heart disease varies by race

Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)

Rates of major CV procedures differ between Medicare Advantage and fee-for-service beneficiaries

Pneumococcal vaccine associated with a decrease in pneumonia hospitalizations

Pneumococcal vaccine associated with a decrease in pneumonia hospitalizations

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.